Lazard Asset Management LLC Ac Immune Sa Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$2.66 - $4.87 $27,291 - $49,966
10,260 New
10,260 $30,000
Q3 2020

Nov 13, 2020
SELL
$4.78 - $9.06 $27,441 - $52,013
-5,741 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$6.57 - $8.3 $3,455 - $4,365
-526 Reduced 8.39%
5,741 $38,000
Q1 2020

May 14, 2020
BUY
$4.24 - $9.89 $18,350 - $42,803
4,328 Added 223.21%
6,267 $43,000
Q4 2019

Feb 13, 2020
BUY
$4.56 - $8.78 $8,841 - $17,024
1,939 New
1,939 $16,000

Others Institutions Holding ACIU

# of Institutions
47
Shares Held
27.9M
Call Options Held
150K
Put Options Held
12.4K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $224M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email